and medical capacity building in other specialties like respiratory care, acute care, emergency pediatric and neonatal care, and more. Additionally, a community awareness session, Merck Foundation ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

NEW YORK – Moderna and Merck will test their personalized neoantigen cancer vaccine V940 with Merck's checkpoint inhibitor Keytruda (pembrolizumab) in certain non-small cell lung cancer patients in a ...

Merck, a leading pharmaceutical company, has embarked on a digital transformation by signing a Memorandum of Understanding with technological innovator Siemens. This partnership will propel digital ...

With these approvals, KEYTRUDA is now authorized for 30 indications in the EU, including five in gynecologic cancers, Merck said in a statement. RAHWAY: Merck, also known as MSD outside the US and ...

Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair processes. Modifi Biosciences, a spin out of Yale University founded in 2021, ...

Merck has acquired Modifi Biosciences, a Connecticut-based biotech, for up to $1.3bn. The acquisition strengthens Merck’s oncology portfolio as the company looks to offset revenue losses from the ...

Gdansk: German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for $600 million, it said ahead of its ...

Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab ... editing by Rachel More and Jan Harvey Online travel giant Booking Holdings said on Friday it expected ...